Update shared on 27 Nov 2025
Fair value Increased 0.0021%Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin.
What's in the News
- Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025. The company is finalizing a successor to ensure a smooth transition and continuity in financial governance. (Company Statement)
- A board meeting on October 27, 2025, will review and approve unaudited financial results for the quarter and half year ended September 30, 2025, and consider the establishment of a new facility for producing Specialty Fluoropolymers. (Company Announcement)
Valuation Changes
- Consensus Analyst Price Target has risen slightly from ₹3,182.93 to ₹3,183.00.
- Discount Rate has increased marginally, moving from 13.49% to 13.50%.
- Revenue Growth projection has decreased modestly from 15.28% to 15.25%.
- Net Profit Margin has edged down slightly, now at 13.31% compared to 13.32% previously.
- Future P/E ratio has climbed a bit, shifting from 44.06x to 44.28x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.